PE  Ampersand Ventures

http://ampersandcapital.com/





     Office Locations:

55 William St., Suite 240
Wellesley, MA 02481
Phone: 781-239-0700
Fax: 781-239-0824

 

Stages:

  • Middle Market


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Ampersand, a middle market private equity firm focused on investments in two core sectors: Healthcare and industrial. The firm targets middle market, growth equity opportunities where it is the first institutional investor. Ampersand's investment team consists of almost 20 professionals managing more than $600 million from the firm's offices in Wellesley, MA. Ampersand originated in 1969 as an internal, technology-focused venture capital investment activity at PaineWebber. Ampersand was then founded in 1988 as a spinoff from PaineWebber, focused on the specialty materials and chemicals (SMC) industry. Over the past two decades Ampersand has managed $1 billion in private equity partnerships.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Dana Niles Partner and COO
    David Parker General Partner
    Eric B. Lev Partner
    Geoffrey P. Teillon Partner
    Herbert Hooper Managing General Partner

     

    Portfolio companies include:


      Agilux Laboratories
        web link


      ATS Labs
        web link


      Biomedical Structures
        web link


      Bioventus
        web link


      Blue Sky BioServices
        web link


      ChanTest
        web link


      CoreLab Partners
        web link


      CRI
        web link


      CutisPharma
        web link


      Dynex Technologies
        web link


      Kortec
        web link


      Magellan Biosciences
        web link


      Magellan Diagnostics
        web link


      MedVenture Technology
        web link


      Modified Polymer Components
        web link


      Nitinol Devices and Components
        web link


      RAND
        web link


      Roadrunner Pharmacy
        web link


      ViraCor-IBT Laboratories
        web link


      Willow Laboratories
        web link


     

    Recent News:


      There is no recent news for Ampersand Ventures.